Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Palatin Begins Phase 2 Trial To Assess Combined Efficacy Of Bremelanotide And Tirzepatide In Obesity Management

Author: Benzinga Newsdesk | June 12, 2024 07:34am

Co-Administration Phase 2 study of bremelanotide with tirzepatide (GLP-1) to provide key information for melanocortin treatments of obesity
Topline data expected by end of calendar year 2024
Additional studies under assessment for multiple metabolic conditions

Posted In: PTN